Are there any reported cases of pseudoporphyria induced by bisoprolol, atorvastatin, or paroxetine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

There are no documented cases of pseudoporphyria caused by bisoprolol, atorvastatin, or paroxetine, as these medications are not commonly associated with this condition. Pseudoporphyria is a rare condition characterized by skin fragility, blistering, and scarring on sun-exposed areas, mimicking the cutaneous findings of porphyria cutanea tarda without abnormalities in porphyrin metabolism. According to a recent study published in Nature Reviews Cardiology 1, several medications have been linked to drug-induced photosensitivity, including angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, anti-arrhythmic drugs, anti-depressant drugs, antimicrobial drugs, β-blockers (specifically tilisolol), calcium channel blockers, diuretics, 3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (such as atorvastatin), non-steroidal anti-inflammatory drugs, and psychotropic drugs. However, bisoprolol, a β-blocker, is not mentioned as a common cause of pseudoporphyria or photosensitivity in this study. Atorvastatin, an HMG-CoA reductase inhibitor, is listed among medications that can cause photosensitivity, but there is no specific mention of it causing pseudoporphyria. Paroxetine, an anti-depressant drug, is also listed among medications that can cause photosensitivity, but again, there is no specific mention of it causing pseudoporphyria. Some key points to consider include:

  • Pseudoporphyria is a rare condition that requires careful diagnosis and differentiation from true porphyria.
  • Medications such as tetracyclines, furosemide, and naproxen have been implicated in causing pseudoporphyria.
  • If symptoms suggestive of pseudoporphyria occur while taking bisoprolol, atorvastatin, or paroxetine, consultation with a dermatologist and the prescribing physician is necessary to evaluate other potential causes or medication interactions.
  • Diagnosis typically involves clinical examination, skin biopsy, and laboratory testing to rule out true porphyria.

From the Research

Pseudoporphyria Cases

  • There are no reported cases of pseudoporphyria caused by bisoprolol, atorvastatin, or paroxetine in the provided studies 2, 3, 4, 5, 6.
  • Pseudoporphyria is a photosensitive bullous disease that resembles porphyria cutanea tarda, but with normal porphyrin levels in urine, stool, and blood 3, 4.
  • The disease is associated with various factors, including chronic renal failure, hemodialysis, certain drugs (e.g., naproxen, nabumetone, furosemide, ciprofloxacin, voriconazole, acitretin), tanning beds, and UVA exposure 3, 4, 5.
  • The provided studies do not mention bisoprolol, atorvastatin, or paroxetine as potential causes of pseudoporphyria 2, 3, 4, 5, 6.

Drug-Induced Pseudoporphyria

  • Nonsteroidal anti-inflammatory agents (NSAIDs), especially naproxen and other propionic acid derivatives, are known to cause pseudoporphyria 5.
  • Other drugs, such as furosemide, ciprofloxacin, voriconazole, and acitretin, have also been associated with pseudoporphyria 3, 4.
  • Paroxetine, a selective serotonin reuptake inhibitor (SSRI), has been studied for its efficacy and safety in treating various disorders, but its potential to cause pseudoporphyria is not mentioned in the provided studies 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical Guide and Update on Porphyrias.

Gastroenterology, 2019

Research

[Clinical review of pseudoporphyria].

Ugeskrift for laeger, 2015

Research

Pseudoporphyria.

Journal of the American Academy of Dermatology, 2001

Research

Pseudoporphyria induced by propionic acid derivatives.

Journal of cutaneous medicine and surgery, 1999

Research

Paroxetine: a review.

CNS drug reviews, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.